2014
DOI: 10.1007/s11030-014-9518-6
|View full text |Cite
|
Sign up to set email alerts
|

Tractable synthesis of multipurpose screening compounds with under-represented molecular features for an open access screening platform

Abstract: The layout of multipurpose screening libraries must address criteria for the compounds such as novelty, diversity potential, innovative design, and last but not least synthetic tractability. While academic compound collections are often innovative, novel, and highly divers, synthesis of analogs or larger substance quantities is often hampered by complex multistep syntheses with low overall yields. In addition, covalently binding compounds and interaction motifs designed to bind metal ions were discriminated ag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…To check the potential application of the demonstrated asymmetric synthesis, the reaction of 55e with MeI and K 2 CO 3 in acetone led to the formation of methylated analog 56 without damage to the two quaternary spiro stereocenters [Scheme 27C]. Notably, there are two privileged substructures, butyrolactone and pyrazolone [82][83][84][85][86][87] , in one spirocyclic molecular structure of 55, which may potentially be useful in medicinal chemistry. .…”
Section: -Isothiocyanato Butyrolactones As C-n-c Synthonsmentioning
confidence: 99%
“…To check the potential application of the demonstrated asymmetric synthesis, the reaction of 55e with MeI and K 2 CO 3 in acetone led to the formation of methylated analog 56 without damage to the two quaternary spiro stereocenters [Scheme 27C]. Notably, there are two privileged substructures, butyrolactone and pyrazolone [82][83][84][85][86][87] , in one spirocyclic molecular structure of 55, which may potentially be useful in medicinal chemistry. .…”
Section: -Isothiocyanato Butyrolactones As C-n-c Synthonsmentioning
confidence: 99%